Intensity of reported local and systemic AEs on each QIV batch.
myalgia, pain
ADVERSE REACTION
Most local and systemic AEs reported in the QIV and TIV groups had mild intensity. Mild pain was the most local adverse reaction, which occurred in 15.3% and 17.8% of the subjects in the QIV and TIV groups, respectively. Mild myalgia was the most systemic adverse reaction, which occurred in 13.6% and 9.6% of the subjects in the QIV and TIV groups, respectively.